Medtronic (Dublin) reported a 12% increase in revenues for the quarter ending on July 31 – bringing in about $7.27 billion. The company said the increase was due in part to its $42.9 billion Covidien acquisition (Medical Device Daily, June 17, 2014).

Heartware (Framingham, Mass.) is stepping into new territory with its latest acquisition and branching out into the mitral valve replacement and repair market. The company, which is known solely for developing ventricular assist devices (VAD) said it would achieve this bold move by acquiring Valtech Cardio (Yehuda, Israel), a private company, in a deal some analysts estimate to be worth $425 million.

Google's (Mountain View, Calif.) life sciences team is once again delving into the diabetes monitoring and treatment space, this time through a partnership with Sanofi (Paris). The companies will work on better ways to collect, analyze and understand multiple sources of information impacting diabetes. The move comes just a few weeks after Google reported entering into an agreement with Dexcom (San Diego) to develop smaller and more affordable continuous glucose monitoring products (Medical Device Daily, Aug. 12, 2015).

Google's life sciences team is once again delving into the diabetes space, this time through a partnership with Sanofi SA, of Paris. They will work on ways to collect, analyze and understand multiple sources of information impacting diabetes. The move comes just a few weeks after Google entered an agreement with Dexcom Inc. to develop smaller and more affordable continuous glucose monitoring products.

While St. Jude Medical (St. Paul, Minn.) and Abbott Laboratories (Abbott Park, Ill.) stole headlines late last week, shooting down rumors of a potential mega merger, Greatbatch's (Frisco, Texas) announcement it would acquire Lake Region Medical(Wilmington, Mass.) for $1.73 billion was almost lost in the shuffle.